Filing Details

Accession Number:
0001179110-20-008462
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-23 17:04:47
Reporting Period:
2020-07-21
Accepted Time:
2020-07-23 17:04:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1712233 J Michael Pederson 100 Abbott Park Road
Abbott Park IL 60064
Senior Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2020-07-21 23,008 $0.00 96,899 No 4 M Direct
Common Shares Without Par Value Disposition 2020-07-21 23,008 $98.00 73,891 No 4 S Direct
Common Shares Without Par Value Disposition 2020-07-21 2,437 $99.08 71,454 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Option (right to buy) Disposition 2020-07-21 23,008 $0.00 23,008 $50.72
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
23,008 2019-07-21 2027-07-20 No 4 M Direct
Footnotes
  1. Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.